Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Effects Of Alternative Food Voucher Delivery Strategies On Nutrition Among Low-Income Adults.

Basu S, Gardner CD, White JS, Rigdon J, Carroll MM, Akers M, Seligman HK.

Health Aff (Millwood). 2019 Apr;38(4):577-584. doi: 10.1377/hlthaff.2018.05405.

PMID:
30933599
2.

An Evaluation of the Glass Vial Hydrolytic Resistance Method.

Sloey C, Gleason C, Akers M, Nashed-Samuel Y, Phillips J.

PDA J Pharm Sci Technol. 2019 May-Jun;73(3):212-219. doi: 10.5731/pdajpst.2018.008896. Epub 2018 Nov 27.

PMID:
30482802
3.

Basics of Sterile Compounding: Particulate Matter.

Akers MJ.

Int J Pharm Compd. 2017 Sep-Oct;21(5):395-404.

PMID:
29216617
4.

Documentation: Records and Reports.

Akers MJ.

Int J Pharm Compd. 2017 Sep-Oct;21(5):373-380.

PMID:
29216613
5.

Quality improvement regarding handoff.

Studeny S, Burley L, Cowen K, Akers M, O'Neill K, Flesher SL.

SAGE Open Med. 2017 Sep 6;5:2050312117729098. doi: 10.1177/2050312117729098. eCollection 2017.

6.

Basics of Sterile Compounding: Excipients Used in Injections.

Akers MJ.

Int J Pharm Compd. 2017 Jul-Aug;21(4):301-308.

PMID:
28719373
7.

Basics of Sterile Compounding: Manipulating Peptides and Proteins.

Akers MJ.

Int J Pharm Compd. 2017 May-Jun;21(3):223-228.

PMID:
28557784
8.

Accuracy Considerations in Sterile Compounding.

Akers MJ.

Int J Pharm Compd. 2017 Mar-Apr;21(2):133-142.

PMID:
28346209
9.

Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.

Akers MJ.

Int J Pharm Compd. 2017 Jan-Feb;21(1):47-56. Review.

PMID:
28346198
10.

Formulation and Stability of Solutions.

Akers MJ.

Int J Pharm Compd. 2016 Mar-Apr;20(2):137-41.

PMID:
27326440
11.

Formulation and Stability of Solutions.

Akers MJ.

Int J Pharm Compd. 2016 Jan-Feb;20(1):41-5.

PMID:
27127830
12.

Basic Principles of Lyophilization, Part 2.

Akers MJ.

Int J Pharm Compd. 2016 Jan-Feb;20(1):20-7.

PMID:
27125053
13.

Sterile Product Packaging and Delivery Systems.

Akers MJ.

Int J Pharm Compd. 2015 Nov-Dec;19(6):491-500. Review.

PMID:
26891564
14.

Basic Principles of Lyophilization, Part 1.

Akers MJ.

Int J Pharm Compd. 2015 Nov-Dec;19(6):471-6.

PMID:
26891561
15.

Sterile Filtration.

Akers MJ.

Int J Pharm Compd. 2015 Sep-Oct;19(5):393-401.

PMID:
26775447
16.

Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.

Akers MJ.

Int J Pharm Compd. 2016 Jul-Aug;20(4):307-314. Review.

PMID:
28333676
17.

Basics of Sterile Compounding: Clinical Hazards of Injectable Drug Administration.

Akers MJ.

Int J Pharm Compd. 2016 May-Jun;20(3):217-222.

PMID:
28333663
18.

Current Perspectives on the Syringe Delivery System.

Akers MJ.

Int J Pharm Compd. 2016 May-Jun;20(3):182-186.

PMID:
28333657
19.

Contamination Control.

Akers MJ.

Int J Pharm Compd. 2015 May-Jun;19(3):232-8.

PMID:
26714364
20.

Quality Assurance and Quality Control, Part 2.

Akers MJ.

Int J Pharm Compd. 2015 May-Jun;19(3):215-21. Review.

PMID:
26714362
21.

BASICS OF STERILE COMPOUNDING: Sterilization Methods in Sterile Product Manufacturing.

Akers MJ.

Int J Pharm Compd. 2015 Mar-Apr;19(2):127-38.

PMID:
26685494
22.

Quality Assurance and Quality Control, Part 1.

Akers MJ.

Int J Pharm Compd. 2015 Mar-Apr;19(2):121-4.

PMID:
26685493
23.

BASICS OF STERILE COMPOUNDING: Barrier Isolator Technologies in Aseptic Processing.

Akers MJ.

Int J Pharm Compd. 2015 Jul-Aug;19(4):315-20.

PMID:
26625569
24.

A Quality Improvement Project to Improve Family Recognition of Medical Team Member Roles.

Hayes RM, Wickline A, Hensley C, Cowen K, Jessie A, Akers M, Dolan J, Pritt A, Goodrich S, O'Neill K, Flesher SL.

Hosp Pediatr. 2015 Sep;5(9):480-6. doi: 10.1542/hpeds.2014-0235.

25.

Microbial Contamination of Enteral Nutrition Mixtures in a Hyperthermal Environment: A Follow-Up Investigation.

Akers KS, Shields BA, Akers ME, Mende K, Beckius ML, Murray CK, Chung KK.

Nutr Clin Pract. 2015 Aug;30(4):582-4. doi: 10.1177/0884533615586203. No abstract available.

PMID:
26206953
26.
27.

Basics of sterile compounding: aseptic processing.

Akers MJ.

Int J Pharm Compd. 2015 Jan-Feb;19(1):49-56.

PMID:
25902628
28.

A population-based cross-sectional study of health service deficits among U.S. adults with depressive symptoms.

Huot KL, Lutfiyya MN, Akers MF, Amaro ML, Swanoski MT, Schweiss SK.

BMC Health Serv Res. 2013 May 1;13:160. doi: 10.1186/1472-6963-13-160.

29.

Examination of pneumococcal vaccination rates among U.S. adult smokers.

Amaro ML, Lutfiyya MN, Akers MF, Swanoski MT.

Am J Health Syst Pharm. 2012 Dec 15;69(24):2154-8. doi: 10.2146/ajhp110623.

PMID:
23230039
30.

Incorporating research into a postgraduate year 1 pharmacy residency.

Swanoski MT, Akers MF, Amaro ML, Huot KL, Lutfiyya MN.

Am J Pharm Educ. 2012 Nov 12;76(9):175. doi: 10.5688/ajpe769175.

31.

Knowledge of heart attack and stroke symptomology: a cross-sectional comparison of rural and non-rural US adults.

Swanoski MT, Lutfiyya MN, Amaro ML, Akers MF, Huot KL.

BMC Public Health. 2012 Jun 1;12:283. doi: 10.1186/1471-2458-12-283.

32.

Pharmaceutical Development and Technology (PDT) announcements.

Akers MJ.

Pharm Dev Technol. 2012 Mar-Apr;17(2):129-30. doi: 10.3109/10837450.2012.660308. No abstract available.

PMID:
22332761
33.

Functional and gene network analyses of transcriptional signatures characterizing pre-weaned bovine mammary parenchyma or fat pad uncovered novel inter-tissue signaling networks during development.

Piantoni P, Bionaz M, Graugnard DE, Daniels KM, Everts RE, Rodriguez-Zas SL, Lewin HA, Hurley HL, Akers M, Loor JJ.

BMC Genomics. 2010 May 26;11:331. doi: 10.1186/1471-2164-11-331.

34.

Practical fundamentals of glass, rubber, and plastic sterile packaging systems.

Sacha GA, Saffell-Clemmer W, Abram K, Akers MJ.

Pharm Dev Technol. 2010 Jan-Feb;15(1):6-34. doi: 10.3109/10837450903511178. Review.

PMID:
20088708
35.

Public perceptions of the podiatrist and the DPM degree.

Akers MD, Vandemark-Teplica JM, Kiss A, Alfieri DM, Jennings MB.

J Am Podiatr Med Assoc. 2009 May-Jun;99(3):223-31.

PMID:
19448173
36.

Solid state chemistry of proteins IV. What is the meaning of thermal denaturation in freeze dried proteins?

Pikal MJ, Rigsbee D, Akers MJ.

J Pharm Sci. 2009 Apr;98(4):1387-99. doi: 10.1002/jps.21517.

PMID:
18704958
37.

Mechanistic studies of glass vial breakage for frozen formulations. II. Vial breakage caused by amorphous protein formulations.

Jiang G, Akers M, Jain M, Guo J, Distler A, Swift R, Wadhwa MV, Jameel F, Patro S, Freund E.

PDA J Pharm Sci Technol. 2007 Nov-Dec;61(6):452-60.

PMID:
18410046
38.

Mechanistic studies of glass vial breakage for frozen formulations. I. Vial breakage caused by crystallizable excipient mannitol.

Jiang G, Akers M, Jain M, Guo J, Distler A, Swift R, Wadhwa MV, Jameel F, Patro S, Freund E.

PDA J Pharm Sci Technol. 2007 Nov-Dec;61(6):441-51.

PMID:
18410045
39.

Top ten hot topics in parenteral science and technology.

Akers MJ, Nail SL, Saffell-Clemmer W.

PDA J Pharm Sci Technol. 2007 Sep-Oct;61(5):337-61. Review.

PMID:
18047174
40.
41.

Correlation of laboratory and production freeze drying cycles.

Kuu WY, Hardwick LM, Akers MJ.

Int J Pharm. 2005 Sep 30;302(1-2):56-67.

PMID:
16099610
42.

Practical formulation and process development of freeze-dried products.

Schwegman JJ, Hardwick LM, Akers MJ.

Pharm Dev Technol. 2005;10(2):151-73. Review.

PMID:
15926665
43.

Drying effects on residual moisture of lyophilization rubber closures.

Kruszynski M, Tempel J, Akers MJ.

PDA J Pharm Sci Technol. 2004 Sep-Oct;58(5):250-3. No abstract available.

PMID:
15568645
44.

Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions.

Taniyama Y, Weber DS, Rocic P, Hilenski L, Akers ML, Park J, Hemmings BA, Alexander RW, Griendling KK.

Mol Cell Biol. 2003 Nov;23(22):8019-29.

45.

Pelvic inflammatory disease and sepsis.

Dulin JD, Akers MC.

Crit Care Nurs Clin North Am. 2003 Mar;15(1):63-70. Review.

PMID:
12597041
46.

Mechanism of hydrogen peroxide-induced cell cycle arrest in vascular smooth muscle.

Deshpande NN, Sorescu D, Seshiah P, Ushio-Fukai M, Akers M, Yin Q, Griendling KK.

Antioxid Redox Signal. 2002 Oct;4(5):845-54.

PMID:
12470513
47.

Excipient-drug interactions in parenteral formulations.

Akers MJ.

J Pharm Sci. 2002 Nov;91(11):2283-300. Review.

PMID:
12379914
48.

Formulation development of protein dosage forms.

Akers MJ, Vasudevan V, Stickelmeyer M.

Pharm Biotechnol. 2002;14:47-127. Review. No abstract available.

PMID:
12189730
49.

State of pharmaceutics in 2002.

Akers MJ.

Pharm Dev Technol. 2002 Jan;7(1):v-vi. No abstract available.

PMID:
11852702
50.

Drugs of the future: lessons of the past.

Akers MJ.

Pharm Dev Technol. 2001;6(2):v-vi. No abstract available.

PMID:
11417003

Supplemental Content

Support Center